07 April 2023 : Original article
Postoperative Outcomes in 415 Patients Following Liver Transplantation Using Extended Donor Criteria: A Study from a Single Center in Germany
Aladdin Ali Deeb1ACE*, Utz Settmacher1D, Johannes Fritsch1BC, Felix Dondorf1AD, Oliver Rohland1F, Falk Rauchfuß1DEDOI: 10.12659/AOT.939060
Ann Transplant 2023; 28:e939060
Table 2 Incidence of EDC and other related factors.
| Variable | Categorical scale* | Interval scale |
|---|---|---|
| EDC | 334 (80.5%) | |
| Malignancy | 4 (1%) | – |
| Drug abuse | 2 (0.5%) | – |
| Viral hepatitis | 25 (6%) | – |
| Sepsis | 5 (1.2%) | – |
| Meningitis | 4 (1%) | – |
| Age (y) | 163 (39.3%) | 60 (2 to 83) |
| ICU-stay (d) | 93 (22.4) | 3 (1 to 22) |
| BMI (kg/m) | 65 (15.7%) | 26 (15 to 43) |
| Hepatic steatosis (%) | 7 (1.7%) | – |
| sNa (mmol/l) | 12 (2.9%) | 147 (126 to 185) |
| sGOT/sGPT (U/l) | 103 (24.8%) | 31 (5 to 1176) |
| sBilirubin (mg/dl) | 2 (0.5%) | 9.7 (1 to 151) |
| Other | ||
| CIT (h) | – | 8.2 (2.8 to 17) |
| Resuscitation | 92 (22.2%) | – |
| Sex | m 208 (50.1%), w 207 (49.9%) | – |
| ICU – Intensive Care Unit, BMI – body mass index; sNa – serum sodium; sGOT – serum glutamic oxaloacetic transaminase; sGPT – serum glutamic pyruvic transaminase; sBilirubin – serum bilirubin; CIT – cold ischemic time. * According to defined cutoff values through German Medical Association: – Age >65 years; – ICU-Stay >7 days; – BMI >30 kg/m; – Hepatic steatosis >40%; – sNa >165 mmol/l; – sGOT/sGPT >3×cutoff value; – Bilirubin >mg/dl. Representing all 415 included patients. | ||